Kawaguchi Chemical IndustryKawaguchi Chemical Industry Co., Ltd4361東証スタンダード化学FY ending Nov 2025, consolidated, J-GAAP

Kawaguchi Chemical Industry FY ending Nov 2019 results

About 99% of Kawaguchi Chemical Industry's sales come from Pharmaceutical products, with Real estate leasing making up much of the rest.

Out of every ¥100 of sales, about ¥3 is left as operating profit.

Where the money goes

For every ¥100 Kawaguchi Chemical Industry sells, how much goes where, and how much is kept.

FY ending Nov 2019

Margin funnel (derived from reported values)Gross margin 17.6% → Operating margin 2.5% → Net margin 2.0%

Revenue by business segment, and the profit each one keeps.

FY ending Nov 2019

Pharmaceutical products¥7.45B
99%
Op. margin 2.2%Industry: Chemicals
Real estate leasing¥37.9M
1%
Op. margin 79.9%Industry: Real Estate Development & Leasing

※ Segment figures include inter-segment sales and do not sum to the company total

Show source documents (3)

EDINET (FSA Japan)
有価証券報告書－第122期(2022/12/01－2023/11/30)
ID S100SXGS2024-02-22Open
EDINET (FSA Japan)
有価証券報告書－第120期(令和2年12月1日－令和3年11月30日)
ID S100NJFA2022-02-24Open
EDINET (FSA Japan)
有価証券報告書－第119期(令和1年12月1日－令和2年11月30日)
ID S100KV872021-02-25Open

Extracted from XBRL: 44 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.